<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02274168</url>
  </required_header>
  <id_info>
    <org_study_id>AIDEG-VTA</org_study_id>
    <nct_id>NCT02274168</nct_id>
  </id_info>
  <brief_title>Utility of ICD Electrograms During Ventricular Tachycardia Ablation</brief_title>
  <official_title>Aid of Recording ICD Electrograms During Monomorphic Ventricular Tachycardia Ablation Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Hospital de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Hospital de Madrid</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the increasing use of implantable cardioverter defibrillators (ICD) for primary
      prevention in patients with structural heart disease, an increasing number of patients are
      expected to develop their first episode of monomorphic ventricular tachycardia (VT) after an
      ICD is in place and the only documentation of the clinical arrhythmia will be the ICD
      electrogram (EG). The absence of a 12-lead ECG in patients with an ICD and sustained
      monomorphic VT represents a limitation when performing treatment with radiofrequency (RF)
      ablation. The analysis of ICD-EG during a RF ablation procedure is expected to provide a
      reference &quot;model&quot; of VT with clinical expression consisting of the electrical signal of the
      ICD during VT (which otherwise is not generally possible to obtain in ICD patients). This
      will allow for a more targeted approach to the substrate of the VT with clinical expression
      because: 1) if VT is induced by programmed stimulation, one can tell whether it is with
      clinical expression or not, and 2) if VT is not induced, ventricular pacing could be
      performed based on the comparative analysis of morphology and activation times of ICD-EG.
      These approaches will result in improved outcomes of the ablation procedure.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2011</start_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients free of VT recurrence</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in number of VT recurrence</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in the proportion of patients free of VT recurrence</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in the proportion of patients free of recurrence in patients in whom 12-lead ECG of the spontaneous VT is not available and in those in whom hemodinamically tolerated VT is not induced</measure>
    <time_frame>6 months and total follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of spatial resolution of the ICD-EG after information from local ventricular endocardial acceleration is added</measure>
    <time_frame>6 months</time_frame>
    <description>This outcome will be studied from the stored signal together with the ICD-EG on the device in the subgroup of patients with a device that allows to obtain this parameter. In the remaining patients, signals will be obtained noninvasively with a seismocardiogram using a highly sensitive accelerometer located in the sternal midline of the xiphoid process and simultaneously synchronized with the ECG.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Sustained Monomorphic Ventricular Tachycardia</condition>
  <arm_group>
    <arm_group_label>Conventional RF catheter ablation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Conventional RF ablation will be performed without using ICD-EG information</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Investigational RF Catheter Ablation using ICD-EG information</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>RF Catheter Ablation will be performed using ICD-EG information</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional RF catheter ablation</intervention_name>
    <description>RF catheter ablation will be performed as usually done by each center. No ICD EGMs will be obtained and used during the ablation procedure (do not place the programming head over the ICD generator).</description>
    <arm_group_label>Conventional RF catheter ablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Investigational RF Catheter Ablation using ICD-EG information</intervention_name>
    <description>RF ablation procedure will be performed with the programming head over the ICD generator. ICD EGMs will be registered every time VT is induced and during ventricular pacing. ICD EGMs obtained during ablation procedure will be compared with the EGMs of the registered spontaneus VT and used to locate appropriate ablation sites.</description>
    <arm_group_label>Investigational RF Catheter Ablation using ICD-EG information</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Clinical indication for RF catheter ablation

          -  Presence of an implanted ICD

          -  At least 1 episode of spontaneous sustained monomorphic VT documented with ICD
             electrogram

          -  Presence of structural heart disease

          -  Able to obtain signed informed consent and willing to comply with study activity
             requirements

        Exclusion Criteria:

          -  It is anticipated that data can not be obtained during follow-up

          -  Unwilling or unable to provide informed consent

          -  Women who are or may potentially be pregnant

          -  Patients who are participating in another clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jesus Almendral, MD</last_name>
    <role>Study Director</role>
    <affiliation>HM Hospitales</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mercedes Ortiz, PhD</last_name>
    <phone>+34 607257825</phone>
    <email>electrofisiologia.hms@hmhospitales.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital General Universitario</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Luis Ibañez, MD</last_name>
      <email>ppluic@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Jose Luis Ibañez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrique Rodríguez, MD</last_name>
      <email>erodriguezf@santpau.cat</email>
    </contact>
    <investigator>
      <last_name>Enrique Rodríguez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julio Martí, MD</last_name>
      <email>jmarti@parcdesalutmar.cat</email>
    </contact>
    <investigator>
      <last_name>Julio Martí, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Basurto</name>
      <address>
        <city>Bilbao</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Ormatexe, MD</last_name>
      <email>JOSEMIGUEL.ORMATXEMERODIO@osakidetza.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Burgos</name>
      <address>
        <city>Burgos</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier García, MD</last_name>
      <email>javyergf7@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>Javier García, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de las Nieves</name>
      <address>
        <city>Granada</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Alvarez, MD</last_name>
      <email>malvarezl@secardiologia.es</email>
    </contact>
    <investigator>
      <last_name>Miguel Alvarez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Insular de Gran Canaria</name>
      <address>
        <city>Las Palmas</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olga Medina, MD</last_name>
      <email>OMEDINA@telefonica.net</email>
    </contact>
    <investigator>
      <last_name>Olga Medina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HM Hospitales</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesús Almendral, MD</last_name>
      <email>almendral@secardiologia.es</email>
    </contact>
    <investigator>
      <last_name>Jesús Almendral, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael Peinado, MD</last_name>
      <email>rpeinado@secardiologia.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier Moreno, MD</last_name>
      <email>jmoreno@secardiologia.es</email>
    </contact>
    <investigator>
      <last_name>Javier Moreno, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Arrixaca</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arcadio García Alberola, MD</last_name>
      <email>arcadi@secardiologia.es</email>
    </contact>
    <investigator>
      <last_name>Arcadio García Alberola, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Nuestra Señora de Valme</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dolores García Medina, MD</last_name>
      <email>lolagarciamedina@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Dolores García Medina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Salud</name>
      <address>
        <city>Toledo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Angel Arias, MD</last_name>
      <email>maapalomares@secardiologia.es</email>
    </contact>
    <investigator>
      <last_name>Miguel Angel Arias, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo Ruiz Granell, MD</last_name>
      <email>ricardo.ruizgranell@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ricardo Ruiz Granell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Yoshida K, Liu TY, Scott C, Hero A, Yokokawa M, Gupta S, Good E, Morady F, Bogun F. The value of defibrillator electrograms for recognition of clinical ventricular tachycardias and for pace mapping of post-infarction ventricular tachycardia. J Am Coll Cardiol. 2010 Sep 14;56(12):969-79. doi: 10.1016/j.jacc.2010.04.043.</citation>
    <PMID>20828650</PMID>
  </reference>
  <reference>
    <citation>Almendral J, Marchlinski F. Is it the same or a different ventricular tachycardia?: an additional use for defibrillator electrograms. J Am Coll Cardiol. 2010 Sep 14;56(12):980-2. doi: 10.1016/j.jacc.2010.03.081.</citation>
    <PMID>20828651</PMID>
  </reference>
  <reference>
    <citation>Almendral J, Atienza F, Everss E, Castilla L, Gonzalez-Torrecilla E, Ormaetxe J, Arenal A, Ortiz M, Sanromán-Junquera M, Mora-Jiménez I, Bellon JM, Rojo JL. Implantable defibrillator electrograms and origin of left ventricular impulses: an analysis of regionalization ability and visual spatial resolution. J Cardiovasc Electrophysiol. 2012 May;23(5):506-14. doi: 10.1111/j.1540-8167.2011.02233.x. Epub 2011 Dec 8.</citation>
    <PMID>22151407</PMID>
  </reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2014</study_first_submitted>
  <study_first_submitted_qc>October 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 24, 2014</study_first_posted>
  <last_update_submitted>September 24, 2015</last_update_submitted>
  <last_update_submitted_qc>September 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

